Biblio
Export 1991 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is B [Clear All Filters]
“Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 185-192, 2017.
, “Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1547-1565, 2017.
, “Validity of a Newly Developed Measure of Memory: Feasibility Study of the Virtual Environment Grocery Store.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1227-1235, 2017.
, “Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1019-1029, 2017.
, “Visual Rating of Posterior Atrophy as a Marker of Progression to Dementia in Mild Cognitive Impairment Patients.”, J Alzheimers Dis, vol. 55, no. 1, pp. 137-146, 2017.
, “Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1223-1227, 2017.
, “Vitamin D Insufficiency and Cognitive Function Trajectories in Older Adults: The Rancho Bernardo Study.”, J Alzheimers Dis, vol. 58, no. 3, pp. 871-883, 2017.
, “Vitamin D Insufficiency and Cognitive Function Trajectories in Older Adults: The Rancho Bernardo Study.”, J Alzheimers Dis, vol. 58, no. 3, pp. 871-883, 2017.
, “Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study.”, J Alzheimers Dis, vol. 60, no. 2, pp. 335-340, 2017.
, “Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study.”, J Alzheimers Dis, vol. 60, no. 2, pp. 335-340, 2017.
, “Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study.”, J Alzheimers Dis, vol. 60, no. 2, pp. 335-340, 2017.
, “Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study.”, J Alzheimers Dis, vol. 60, no. 2, pp. 335-340, 2017.
, “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
, “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
, “White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.”, J Alzheimers Dis, vol. 55, no. 1, pp. 333-342, 2017.
, “White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.”, J Alzheimers Dis, vol. 55, no. 1, pp. 333-342, 2017.
, “White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.”, J Alzheimers Dis, vol. 55, no. 1, pp. 333-342, 2017.
, “Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.”, J Alzheimers Dis, vol. 56, no. 2, pp. 763-774, 2017.
, “Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.”, J Alzheimers Dis, vol. 56, no. 2, pp. 763-774, 2017.
, “A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1325-1335, 2018.
, “A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1325-1335, 2018.
, “18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1175-1194, 2018.
, “18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1691-1702, 2018.
, “[18F]-Flutemetamol Uptake in Cortex and White Matter: Comparison with Cerebrospinal Fluid Biomarkers and [18F]-Fludeoxyglucose.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1595-1607, 2018.
, “ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1195-1211, 2018.
,